EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 217 filers reported holding EDITAS MEDICINE INC in Q2 2018. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $848,967 | -44.4% | 108,842 | -41.4% | 0.00% | -100.0% |
| Q2 2023 | $1,527,826 | -57.7% | 185,641 | -62.7% | 0.00% | 0.0% |
| Q1 2023 | $3,609,515 | -0.0% | 497,864 | +22.3% | 0.00% | 0.0% |
| Q4 2022 | $3,610,214 | +231.8% | 407,014 | +357.8% | 0.00% | – |
| Q3 2022 | $1,088,000 | -67.2% | 88,901 | -68.3% | 0.00% | -100.0% |
| Q2 2022 | $3,322,000 | -27.7% | 280,864 | +16.3% | 0.00% | -50.0% |
| Q1 2022 | $4,595,000 | +22.4% | 241,583 | +70.8% | 0.00% | +100.0% |
| Q4 2021 | $3,755,000 | -4.4% | 141,435 | +48.0% | 0.00% | 0.0% |
| Q3 2021 | $3,927,000 | -31.0% | 95,596 | -4.8% | 0.00% | -50.0% |
| Q2 2021 | $5,689,000 | +136.3% | 100,441 | +75.2% | 0.00% | +100.0% |
| Q1 2021 | $2,408,000 | -61.0% | 57,331 | -35.0% | 0.00% | -50.0% |
| Q4 2020 | $6,179,000 | +253.3% | 88,135 | +41.4% | 0.00% | +100.0% |
| Q3 2020 | $1,749,000 | -14.6% | 62,313 | -10.0% | 0.00% | 0.0% |
| Q2 2020 | $2,047,000 | +82.3% | 69,218 | +22.3% | 0.00% | 0.0% |
| Q1 2020 | $1,123,000 | -61.1% | 56,616 | -41.9% | 0.00% | 0.0% |
| Q4 2019 | $2,885,000 | -46.7% | 97,435 | -59.1% | 0.00% | -50.0% |
| Q3 2019 | $5,413,000 | +85.6% | 238,005 | +102.0% | 0.00% | +100.0% |
| Q2 2019 | $2,916,000 | -7.0% | 117,846 | -8.1% | 0.00% | 0.0% |
| Q1 2019 | $3,136,000 | +38.4% | 128,280 | +28.8% | 0.00% | 0.0% |
| Q4 2018 | $2,266,000 | -45.3% | 99,616 | -23.5% | 0.00% | -50.0% |
| Q3 2018 | $4,143,000 | +22.9% | 130,187 | +38.4% | 0.00% | +100.0% |
| Q2 2018 | $3,372,000 | -52.5% | 94,084 | -56.0% | 0.00% | -66.7% |
| Q1 2018 | $7,096,000 | +107.9% | 214,038 | +92.7% | 0.00% | +200.0% |
| Q4 2017 | $3,414,000 | -7.9% | 111,091 | -28.0% | 0.00% | -50.0% |
| Q3 2017 | $3,705,000 | +141.1% | 154,303 | +68.4% | 0.00% | +100.0% |
| Q2 2017 | $1,537,000 | -12.0% | 91,606 | +17.1% | 0.00% | 0.0% |
| Q1 2017 | $1,746,000 | +1064.0% | 78,217 | +747.7% | 0.00% | – |
| Q4 2016 | $150,000 | -63.5% | 9,227 | -69.7% | 0.00% | – |
| Q3 2016 | $411,000 | -2.6% | 30,468 | +76.2% | 0.00% | – |
| Q2 2016 | $422,000 | -6.6% | 17,291 | +32.0% | 0.00% | – |
| Q1 2016 | $452,000 | – | 13,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |